Private investment round-up: February 2009

Private investments in pharmaceutical and biotech companies took a healthy leap last month as the funds raised increased by 30% to $273.9 million, compared with January, a Scrip analysis has found.

The amount is more than $100 million above what was raised in February last year, when the credit crunch combined...